32 results match your criteria: "Chulalongkorn University Faculty of Medicine[Affiliation]"
BMJ Support Palliat Care
March 2019
Preventive and Social Medicine, Faculty of Medicine, Chulalongkorn University, Chulalongkorn University Faculty of Medicine, Bangkok, Thailand.
Gut Liver
May 2018
Division of Gastroenterology, Department of Medicine, Chulalongkorn University Faculty of Medicine, Bangkok, Thailand.
Cholangiocarcinoma (CCA) is an aggressive cancer arising from epithelial cells of the bile duct. Most patients with CCA have an unresectable tumor at the time of diagnosis. In Western countries, the risk of CCA increases in patients with primary sclerosing cholangitis, whereas liver fluke infection appears to be the major risk factor for CCA in Asian countries.
View Article and Find Full Text PDFBMJ Case Rep
July 2017
Department of Pediatrics, Chulalongkorn University Faculty of Medicine, Bangkok, Thailand.
Chronic watery diarrhoea can be a presentation of gastrointestinal disease itself or a less-evident systemic disease. A 17-month-old boy presented with intractable diarrhoea, failure to gain weight, refractory tachycardia and severe hypertension. The ability to recognise and make a quick diagnosis of secretory type of diarrhoea dictated the outcome of patients with this ailment.
View Article and Find Full Text PDFClin Exp Dermatol
August 2017
Department of Pathology and Forensic Medicine, Thammasat University Faculty of Medicine, Bangkok, Thailand.
Int J Colorectal Dis
August 2016
Chulalongkorn University Faculty of Medicine, Bangkok, Thailand.
J Travel Med
April 2016
Department of Infectious Diseases, Chulalongkorn University Faculty of Medicine, Bangkok, Thailand.
Int J Radiat Oncol Biol Phys
August 2004
Division of Radiation Therapy, Department of Radiology, Chulalongkorn University Faculty of Medicine, Bangkok 10330, Thailand.
Purpose: Intracavitary brachytherapy plays an important role in the treatment of cervical carcinoma. Previous results have shown controversy between the effect of dose rate on tumor control and the occurrence of complications. We performed a prospective randomized clinical trial to compare the clinical outcomes between low-dose-rate (LDR) and high-dose-rate (HDR) intracavitary brachytherapy for treatment of invasive uterine cervical carcinoma.
View Article and Find Full Text PDF